|
|
||||||||
1 Division of Neurosurgery, The University of Texas Medical Branch at Galveston, Galveston, Texas 77555-0517; and 2 Department of Pharmacology, Milton S. Hershey Medical Center, Hershey, Pennsylvania 17033
NG-nitro-L-arginine methyl ester (L-NAME; 250 µg/5 µl), an inhibitor of NO synthase, or the vehicle artificial cerebrospinal fluid (aCSF; 5 µl) was administered intracerebroventricularly to conscious rats hemorrhaged (0.7 ml/min) to a 20% volume depletion. Hypotension was maximal 5 min after hemorrhage ended, with compensatory recovery to basal levels 20 min later, regardless of drug treatment. L-NAME, however, elevated (P < 0.05) blood pressure (vs. aCSF controls) 40-45 min after intracerebroventricular administration. In normovolemic rats, L-NAME produced a significant pressor response and increased plasma levels of vasopressin (VP) and oxytocin (OT). After hemorrhage, both hormone levels increased, but only OT was further enhanced by L-NAME. Thus centrally produced NO tonically inhibits OT and VP secretion under basal normovolemic conditions and selectively inhibits OT release during hypovolemia. Hemorrhage increased the rates of glucose utilization in the neural lobe, indicative of enhanced efferent neural functional activity. L-NAME further enhanced the metabolic activity in the entire hypothalamoneurohypophysial system of hemorrhaged animals. Several other brain structures involved in the regulation of blood pressure and the stress response were also metabolically affected by the hemorrhage and L-NAME.
nitric oxide; 2-deoxy-D-[14C]glucose; glucose utilization; hypovolemia; neural lobe
This article has been cited by other articles:
![]() |
W. L. Reis, A. Giusti-Paiva, R. R. Ventura, L. O. Margatho, D. A. Gomes, L. L. K. Elias, and J. Antunes-Rodrigues Neuroendocrinology/Endocrinology: Central nitric oxide blocks vasopressin, oxytocin and atrial natriuretic peptide release and antidiuretic and natriuretic responses induced by central angiotensin II in conscious rats Exp Physiol, September 1, 2007; 92(5): 903 - 911. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. Begg, S. Kent, M. J. McKinley, and M. L. Mathai Suppression of endotoxin-induced fever in near-term pregnant rats is mediated by brain nitric oxide Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2007; 292(6): R2174 - R2178. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. Michelini, M. C. Marcelo, J. Amico, and M. Morris Oxytocinergic regulation of cardiovascular function: studies in oxytocin-deficient mice Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H2269 - H2276. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. P. Patel, Y.-F. Li, and Y. Hirooka Role of Nitric Oxide in Central Sympathetic Outflow Experimental Biology and Medicine, October 1, 2001; 226(9): 814 - 824. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Huang, M. Sjoquist, O. Skott, E. M. Stricker, and A. F. Sved Oxytocin antagonist disrupts hypotension-evoked renin secretion and other responses in conscious rats Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2001; 280(3): R760 - R765. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Alfaro, J. Pesquero, and L. Palacios Acid-base disturbance during hemorrhage in rats: significant role of strong inorganic ions J Appl Physiol, May 1, 1999; 86(5): 1617 - 1625. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |